"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker

This episode of Rule Breaker Investing's "Market Cap Game Show" features an epic showdown between two Bills full of humor, precision(!), wild guesses, and a miss by the thinnest of margins.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

• Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $21,805!*
• Apple: if you invested $1,000 when we doubled down in 2008, you’d have $40,295!*
• Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $365,472!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of June 24, 2024

This video was recorded on June 19, 2024.

David Gardner: The price per share of a stock tells you almost nothing. It's the price to buy one share of the stock. But how many shares does the company have outstanding? In math, we multiply two multiplicands together, but the price per share is only one multiplicand. If you don't know the other, you can't do any meaningful math or figure out much of the world around you. Fools with a capital F know that you need to know the shares outstanding, and then multiply that by the price per share, and now you know the actual full value of the company, it's price tag, it's market capitalization. Market cap. Well, to teach this lesson inexorably, and unforgettably. We invented a game. That's what I do. The date was August 9th, 2017. The Market Cap Game Show was born, and we've been playing every quarter since. Oh, and you're playing too. I designed it that way, so you can play along against my guest stars, against your spouse or partner, against your kids. Can you outscore my talented contestants? It's that time of the quarter again, 10 new stocks. Three guest stars, Bill Barker, Bill Mann, and you. Only on this week's Rule Breaker Investing.

It's the Rule Breaker Investing podcast with Motley Fool co-founder, David Gardner.

David Gardner: Welcome back to Rule Breaker Investing. This is the Market Cap Game Show, and our first one following our first ever World Championships completed during this year's March Madness, March market cap Madness. In fact, we have as one of our two guest stars today, the World Champion runner up. Bill, what's a better phrase for that?

Bill Mann: I don't know. I've looked, and I've gone to the Grand Council to try and to figure out if there was some rule that had been violated because I lost by the thinnest of margins.

David Gardner: It was a tie breaker ending. It was a magical ending to our first world championship.

Bill Mann: I would describe it as slightly less magical than if I had won.

David Gardner: Nobody asked you where you were going afterwards, even though we all know Andy Cross went to Disney World. Now, you're right. Unfair. Anyway, I'm going to call you our World runner-up. I hope that sounds like an honorific. Bill Mann back to compete, and Bill will be joined by Bill. Bill Barker. Bill, welcome back to the Market Cap Game Show.

Bill Barker: Thank you, David. Great to be back. Sorry, I couldn't make the World Championships. I was away, I think.

Bill Mann: No, you lost.

Bill Barker: I think you sent in an invitation.

Bill Mann: Didn't you lose?

Bill Barker: No.

David Gardner: You have an opportunity, guys. You don't know this, but you have an opportunity to secure your seat for next year, today. Whoever wins is in, if you lose, you're not necessarily out, but there's an opportunity to secure a 2025 coveted seat in the final four. There will be no excuses, then, Bill. It's unclear which Bill I was saying that to.

Bill Mann: David, the really good news is that you have brought in for this two frighteningly competitive people.

David Gardner: Bills. Welcome back to the Market Cap Game Show. I do want to note Bill Barker last appeared here on our December 2023 Market Cap Game Show just six months ago, Bill you won 6 to 4. So we do, we have two most worthy contestants and most competitive as well here in June 2024. It's worth mentioning that today's game does function, as I mentioned, as a qualifier for next year's World Championships. So the winner today will have his seat on that final four. Guys, no pressure. Bill Barker has been with The Fool for 25 years in between stints as a trial lawyer and federal terrorist asset investigator, but is mostly known in Fool then for inflicting sporadic episodes of Apropos of Nothing on unsuspecting podcast listeners during the days of Market Foolery. He plays a little tennis and other racket sports, roots for the Yankees, and by his own reckoning, sings and dresses about two standard deviations below the median. Back from helping to start up Motley Fool Asset Management, over a decade ago, Bill Barker now writes again for The Fool working on Hidden Gems and Firecrackers. Bill, great to have you.

Bill Barker: Great to be back.

David Gardner: Bill Mann is co-host of the Motley Fools Morning Show, lead advisor for Global Partners and Motley Fool Firecrackers, and a co-advisor for Value Hunters. Bill my bio on you ends there. I feel like the other Bill's was so colorful.

Bill Mann: He sounds so interesting. He's a poor dresser. He can't sing. How much more interesting can you get? I'm going to have this. What other things do you do badly? Mostly everything.

Bill Barker: We don't have time. No.

Bill Mann: We're out of time. I have been known. I'm going to just, like, drop in things that I do. I have been known if you want to know a nice place to eat almost anywhere in the world. For some reason, I have an encyclopedic knowledge.

David Gardner: That is wonderful. That is an asset to all of us, Bill.

Bill Mann: Just ask me.

David Gardner: Love it.

Bill Barker: Why don't we as these companies come up, and you know their headquarters, challenge Bill, on that, because you'll have the information.

David Gardner: That could be awesome or distracting. It's unclear which we might try that once or twice.

Bill Mann: Hi, that might edit it all out. Hi. That's a terrible idea. Let's do it.

David Gardner: Of course, the third player, and to us, the most important is you. That's right, you, our dear fellow Foolish listener. As Des begins to crank up our Market Cap Game Show music. Let me just briefly remind, especially new listeners, new players. I'll be mentioning a stock. Neither Bill nor Bill knows what stock is coming. They've been in the soundproof chamber for, Bill, how long?

Bill Mann: We've been in the soundproof chamber for about 18 minutes at this point. I do question the fact that Bill Barker brought in his computer with him. Which I did not know was part of the rule.

David Gardner: It is closed.

Bill Barker: It is closed.

David Gardner: Believe me. He has no idea what's coming. He's also been part of that so called sound proof chamber. I then turn to one of the Bills here talking about a stock he didn't know was coming, and he will do his best to state a numerical range within which the market cap of that company falls. The other Bill, and you playing at home will simply say, I agree, meaning it's accurate, the stock's value falls inside that range, or I disagree. I think it's outside the stated range. So you simply agree or disagree. If you get it right, give yourself a plus one. That's the Market Cap Game Show. We're focused on the real market caps, real stocks. Nobody knows what's coming. A perfect score would be 10. Stock Number 1. I'm going to turn to our world runner up first, Bill Mann. Bill, I have a phrase for you. So lets play word association. I'm going to flash it out. You're going to share the first thing that comes to mind. Then in a twist, you're going to give us the second thing that comes to mind. After a brief pause where you speak more thoughtfully about it upon brief reflection. Does it sound good?

Bill Mann: It sounds like a psychological experiment. That I might be signing on to, but, yes, I'm here in the soundproof booth.

David Gardner: Excellent.

Bill Mann: I guess we're going to play along.

Bill Barker: Can you repeat back the rules?

David Gardner: Basically, I want to hear your first and second, more thoughtful impressions. Are you ready?

Bill Mann: Yes.

David Gardner: 5G?

Bill Mann: Qualcomm.

David Gardner: What's the second thing that comes to mind?

Bill Mann: Doesn't work all the time.

David Gardner: I kind of agree with you. I'm not going to say it's been overhyped, but I haven't noticed this huge change in my own smartphone experience. Whether it said 5G now or 4G before, there is 3G and 2G as well. I'm not trying to be a cranky old guy about this.

Bill Mann: They need a few more Gs, I think.

Bill Barker: I was going to go with conspiracy theory. It's one of the things that came. The number of conspiracy theories which seem to be out there about 5G is vastly greater in number than the times in which I've realized 5G might be intersected in reality with my life.

David Gardner: I don't read the same websites that you do, Bill.

Bill Barker: No.

Bill Mann: Barker does love a good conspiracy.

Bill Barker: I don't know what the conspiracy's theories are, but they're out there about 5G.

David Gardner: So this company has been behind the various Gs for quite a while now. It's most famous co-founder Irwin Jacobs is now 90-years-old. He's the board chair, by the way of the Salk Institute, guys. Founded in 1960. You probably know this. I need to relook it up by Jonas Salk himself, invented the polio vaccine. But yes, when Bill's first impression came out Qualcomm, he nailed the San Diego based company that is stock number one. So turning now back to Bill Mann, Bill, what is your stated market cap range? For Qualcomm ticker symbol Q-C-O-M.

Bill Mann: So the first year that Barker and I were working here at The Motley Fool was the year that Qualcomm first came onto the scene, and it was up in 1999, like, 26 times, and was pretty flat after that for a really long time. I believe that the market cap is somewhere in 82 billion and 124 billion.

David Gardner: Eighty-two billion to 124 billion for a company that you both got to know as younger Fools. In and around Fool HQ. I had forgotten. Went 24 bagger in one year.

Bill Mann: Its crazy.

David Gardner: Bill Barker, players at home, Bill just said 82 billion-124 billion for Qualcomm. Bill agree or disagree.

Bill Barker: I disagree.

David Gardner: You are correct. It is well more than what Bill Mann provided.

Bill Barker: Its about 220.

David Gardner: Pretty good call. This is as of Monday's market close for all of these. It is an even $248.00 billion, Qualcomm.

Bill Barker: A lot of that's been in the last nine months. Your range would have been good a year ago, I want to say.

David Gardner: Is this a stock that either of you are actively following or have ever recommended?

Bill Mann: Apparently not.

David Gardner: One of you appears to follow it a little bit more than the other. We don't need to follow everything.

Bill Mann: No.

Bill Barker: No, just because of the recent Apple news and things like that, It was back on the radar screen just as a hey, whatever happened to that thing moment.

Bill Mann: I followed it for a long time, if for nothing else, because my theory was in 1999, that a whole lot of growth had been priced in.

David Gardner: Whenever a stock goes up 24 times in one year.

Bill Barker: A generation's growth had been priced in.

Bill Mann: It was a long time that it was actually below that range for a while. So I'm a little surprised that it's grown that much, but maybe it should be.

David Gardner: Fun fact guys. Spoiler alert. Qualcomm has the largest market cap of any company on this week's show. Spoiler alert. Players at home, if you said, disagree. Give yourself a plus one. I have it as Barker one, Mann, nothing. Let's move on to stock number two. Bill Barker, cats or dogs?

Bill Barker: Both, but dogs, if I have to rank.

David Gardner: Do you think people should make invidious distinctions between these two very popular pets? Can't we just get along say, I like your answer both?

Bill Barker: There's quite a distinction between them. It would be sad if you couldn't tell the difference between them. But, I had to bring the cat into the vet yesterday for just a skin thing. I've ranked cats a little bit lower because the vet bill was more than it needed to be in my opinion, given the skin situation, I would have preferred the bill to be about one-fifth of what it was. Had that been the case, I might be ranking cats a little higher.

Bill Mann: See, I think you should use a plan when you go into the vet and say something like, "Here's my cat. You know I'm a dog person. How much will this be?"

Bill Barker: I'm going to give you a range on what this should cost.

David Gardner: Well, speaking of cost, Bill Barker, what is the process by which you have fed your pets? Your cat, for example.

Bill Barker: The process is to get, well, for this cat, I got to get like this special food and then pour it into this big container.

David Gardner: Where do you get the special food from?

Bill Barker: I get the special food from PetSmart.

Bill Mann: You could pay more.

Bill Barker: I'm going to guess what this is leading up to is Chewy. I'll do that. Just make a guess here.

David Gardner: You guessed right.

Bill Barker: Alright.

David Gardner: We didn't even have to play word association. Chewy, ticker symbol C-H-W-Y. Of course, the online pet food retailer, a favorite among some Fools. We'll talk in a bit what you think of this stock if you think anything, Bill. But more importantly, Bill Barker, what is your stated market cap range for Chewy ticker symbol C-H-W-Y?

Bill Barker: I'm going to say 9-11 billion.

David Gardner: Nine billion to 11 billion sticking with round numbers makes it easy for all of us. Thank you, Bill Barker. Bill Mann, players at home?

Bill Mann: It is inside of that.

David Gardner: You are correct, which ties the game at one to one players at home, if you agreed with Bill Barker's pretty tight, very impressive range, then give yourself a plus one because 9.94 billion, basically 10, you straddled it on either side, Bill, your Chewy.

Bill Barker: I felt good about that range. I felt that I would be right, but I needed to be a lot tighter.

David Gardner: It's true. Part of the charm of the game is you can make an awesome guess and lose.

Bill Barker: If you study ahead of time, if you happen to have done that.

Bill Mann: This is why I'm questioning the computer.

Bill Barker: You're using market caps from a couple of days ago, so you still might not, even if you had a very good memory.

David Gardner: I think it's going to stay within 9-11 this week. We'll see. But well done. Founded in 2011. Do you know the original name of this company? It was Mr. Chewy. Mr. Chewy. By 2017, the company had about two billion dollars in revenues, just six years later. It had 51% of the online pet food sales in the US in six years. Wow. Company was initially aiming to go public. You may remember that year, but then both Petco and PetSmart approached with merger offers, and PetSmart, Bill, where you get your cats food, the special food that you get, ultimately bought them for $3.35 billion. It operated independently in 2020. I had lost track of this. You guys will probably keep it up. They reorg'd in such a way that it could go public. PetSmart, by the way, no longer owns any Chewy.

Bill Barker: One of them, Petco, I think Petco, came really close to going, like below a dollar or did get to below a dollar share or something like that.

Bill Mann: Generally speaking, we should say here on the Market Cap Game in the United States, that's bad.

David Gardner: That is bad. Do you guys follow Chewy? Do you have any opinions here?

Bill Mann: Chewy, to me, is a bit of a miraculous company in that it is a company that came to be in that space after Amazon existed.

David Gardner: You're right.

Bill Mann: All of the companies that, there are so many companies that you view as being either Amazon-proof or Amazon susceptible. You would say that having pet food and pet medications delivered to your door is highly Amazon susceptible, but they've done a great job.

Bill Barker: They have done a great job, but I don't know where the market cap compares to, like, the top market cap it had. But there was, I think entirely too much enthusiasm that somehow everybody was going to be using Chewy because it was a good service. People who are already on Amazon getting the same food delivered at the same price and had loyalty with Amazon, and there are plenty of people that will, there's plenty of competition for Chewy. It's done a good job, but the fact that people love their pets does not translate to loving Chewy to the degree that its supporters thought or hoped might be the case.

David Gardner: That is certainly fair. The stock did once touch 120 during that Halcion month of February 2021 before a lot of stocks lost a lot of value from their COVID heights. So yes, it's a pale shadow at $25 a share of what it once was just a few years ago, but still a robust business for a lot of customers.

Bill Mann: An impressive cap.

David Gardner: If you think of it as a standing start from 13 years ago, it's a remarkable story. But more importantly, Bill Mann, you have tied up this game 1-1, players at home, again, give yourself a plus one for agreeing. Let's move to stock number three. Bill Mann. Do you sleep well at night?

Bill Mann: Sometimes I make a few mistakes.

David Gardner: Do you sleep well at night, even when you've picked a losing stock for our services?

Bill Mann: No, not at all. Which means I haven't slept in years.

David Gardner: Like this stock for me, what if it was a horrendously bad pick? Would you sleep even worse?

Bill Mann: David, I know what you're getting at, but you know that that is actually part of the game. When you make a stock pick, when you invest in something, you're investing entirely in the future, and sometimes the future doesn't go the way you thought it was going to. If that causes you to lose sleep, it shouldn't.

David Gardner: Well, a really bad stock pick and sleep combined very well for stock Number 3, whose ticker symbol is SNBR. Some of us sleep on them. I don't have one, Sleep Number, the mattress company. I'm a 64, my partner is a 15, we've dialed the sleep number differently on our mattress. Well, I'll talk about the stock pick and where it was when I made it, but more importantly, I think a lot of us will be familiar with the brand Sleep Number. This is a company Select Comfort, old pick back in the day from Motley Fool Services that eventually rebranded itself because a lot more people would know Sleep Number than Select Comfort. Bill, Man, what is your stated market cap range? These days, for sleep number, ticker symbol, SNBR.

Bill Mann: This was an old hidden gem company, which meant that the top market cap could be $2 billion, but that was 2004. I am going to say 3.1-5.5 billion.

David Gardner: Three point one billion to 5.5 billion, Bills range. Bill Barker, players at home, agree or disagree.

Bill Barker: This company has visited a lot of interesting market caps over the years.

David Gardner: At one point, I remember it was down to Pennies back in its Select Comfort days, and then it made one of the great comebacks in recent market history.

Bill Barker: Yeah.

David Gardner: I have been flagging it. Well, I won't say anything more about it.

Bill Mann: It took another hit down. I'm going to say it's below that. I'm going to disagree.

David Gardner: That is correct. If you disagreed with Bill Mann's assertion, 3.1-5.5, give yourself a plus one. I hope I didn't tilt it there. I may have slightly hinted that. I almost never do that as a host, but my apologies if anybody thought since I was talking about what a bad stock picket was of mine.

Bill Mann: The Grand Council is going to be here and for me again.

Bill Barker: I feel like, you know, the scoring here, even though I'm going to get the point and be ahead of you and have double your score at this point of the game. [laughs] Maybe it doesn't take any skill to just disagree with your range every time. Maybe that takes no more skill.

David Gardner: The game outside the game.

Bill Barker: Your agreeing with my correct ranges is easy to do. It's easy for me to disagree with your incorrect ranges.

David Gardner: We'll see if this holds.

Bill Barker: That is, the game will just go five-five. Somehow, you'll be tied through ineptness with my eptness.

Bill Mann: I think if we're looking at pyrrhic victories here, that the most powerful play so far has been agreeing with your incredibly tight range and being correct.

David Gardner: I think those are both impressive and let's give Bill Barker his plus one that he's talking about. You at home, if you disagree with the range, because I regret to say Sleep Number is well below even the low range of Bill Mann's market cap. It's $269.97 million. It's a sub-$300 million company at this point. Now, it's time for me to say that I picked the stock in February of 2021.

Bill Mann: I'll see it. [laughs]

David Gardner: Remember, we talked about February 2021? It was right around where Chewy was in February 2021, $125 a share right around there, today 12.

Bill Mann: That's lower.

David Gardner: That's lower. It's a lot lower. The market cap actually is below 300 million at this point. It starts making me wonder, and this isn't my style of investing, but it's a pretty well-known brand name that on its own might be worth that or more to an acquisitor, potentially, but we're not here to suggest mergers and acquisitions. We're just here to call out market caps and trash talk.

Bill Mann: But maybe they should think about it.

David Gardner: Well, before we move on to stock number four, I will just remind listeners of one of my cardinal rule-breaker investing points, and I think both Bills would agree with this, as well. In general, we try not to add to our losers, I much prefer to add to my winners. So if you don't add to a stock as it goes from 125 down to 12, it actually becomes irrelevant for your portfolio. The percentage of allocation just diminishes to the point that you're just crying into your soup, laughing a little bit, as you review your portfolio statement and see that you pick Sleep Number.

Bill Mann: I'm not going to take it personally at all, that when you said, add to your losers that you gesticulated toward me.

David Gardner: Not at all. People can't see that at home. This is an audio-only podcast. Let's move on to stock number four. Bill Barker, when you think of hometown pride. I think you call Philadelphia your native tribal home.

Bill Barker: Yes.

David Gardner: What comes to mind for you? What do Philadelphians take pride in? And or what do you take hometown pride in?

Bill Mann: Philadelphians take pride in the Eagles.

David Gardner: I agree with that team.

Bill Barker: More than anything, I would say, just about the most unifying thing in the city.

Bill Mann: Even more so than the cream cheese?

David Gardner: Cheesesteak?

Bill Barker: Yes. Cheesesteak is maybe number one A, Eagles. They go well together.

David Gardner: Bill, are these things that you take hometown pride in when you think about your native tribal home?

Bill Mann: Certainly the cheesesteak. I'm not enough of an Eagles fan to claim to be an Eagles fan around real Eagles fans. I do not suffer from their losses. I grew up with a different football team that I've followed for reasons that are too boring to go into right now, but I now root for the Eagles, just because I do want good things to happen to the city, and there is nothing the city would take more pride and joy from.

David Gardner: Than the Eagles winning again. What about public companies? Hometown pride and Companies. Growing up, was there a Philly company that you all were like, so glad they're in our city?

Bill Mann: I am going to think. I know somebody who came from the Aramark side of things. I think of that one, which was not public at the time. I knew her and was in a play with her, but that's the first one that came to mind.

David Gardner: Well, obviously, Philadelphia is part of your past. It's in your rearview mirror. You've raised your family, Bill, in the Washington DC Metro area. What do you take pride in here?

Bill Barker: Our phenomenal government. [laughs].

David Gardner: Sarcasm is the wit of Fools.

Bill Mann: Good job with the data centers.

David Gardner: We do have a lot of data centers, but what about public companies? Are there any that come to mind that you would take or maybe you pointed out proudly to your son, they're in our city. They started here. Let me suggest one for you, Bill. You don't have to have an answer because CAVA Group, ticker symbol CAVA was founded here in Rockville, Maryland in the greater DC area in 2006, and that is stock number four. I assume you've eaten there. I'm guessing you might have ordered in. CAVA Group, ticker symbol CAVA, a relatively newly listed public company. Bill Barker, what is your stated market cap range for CAVA Group?

Bill Barker: I'm going to say 9.7-10.7 billion.

David Gardner: Earlier, he said nine and 11, and then you easily guessed it so now he's going with the decimals.

Bill Mann: I'm getting angrier and angrier the fact that his computer is sitting right here.

Bill Barker: As if I could look through it.

David Gardner: I want to make it very clear, it's been closed the entire time. I would never ever allow that. That's why we do this in person, guys. This is not a Zoom thing.

Bill Barker: I'm going to set this up right now, and I'm this is the poker play that I'm going to use. I'll see it. Just agree with it. Just agree because I'm nailing these. There's no way I've got this wrong.

David Gardner: Players at home.

Bill Barker: That's that's your best move right now.

David Gardner: Bill Mann, Bill Barker just stated 9.7-10.7 billion. Bill Mann, players at home, agree or disagree?

Bill Mann: I believe that it is just a bit outside.

David Gardner: This is why I love doing this show. Plus one for Bill Mann, if you disagree, give yourself a plus one, as well, because here is literally the market cap of CAVA as Monday's market close occurred. Again, Bill said 9.7 to 10.7, then Bill Mann said, I disagree. I think it's just outside $10.71 billion, astonishing. I'm almost speechless. We've never had a 0.01 miss that got called saying, it was just outside that range.

Bill Mann: Angel Hernandez would have called that a strike clue.

Bill Barker: What I want is a tennis player's challenge on that. I want the live market cap right now.

David Gardner: We could play this another 100 years, and I hope we do, and that will not happen again. That is remarkable. The company founded in Rockville, Maryland, as I mentioned, It has a full-service restaurant with a more traditional dining experience. I think that's maybe how it started, or they added it early in Rockville, Maryland. There are a few others, Cava Mezze. Well, as a DC guy, I like this company. I take some hometown pride in, own a few shares myself as well. By the way, CEO Brett Schulman will be appearing at this year's Fool Fest in July. We'll get to see him. I'm not sure, maybe one of you guys will interview Brett, but we're looking forward to that. Wow, I think the score is two to two.

Bill Mann: I think I get an extra point for that.

Bill Barker: Why should you get it? [laughs] I'm the one who keeps nailing the ranges.

David Gardner: Let's move on to stock number five. Turning now back to Bill Mann. Bill, do people intentionally say things to you because of your surname like, you the man? Are you over-indexed that way?

Bill Mann: I get man, Bill, and then laughter. A bit.

David Gardner: When you think of American public companies that, in some way, include your own name? Which come to mind?

Bill Mann: There's bill.com.

David Gardner: I hadn't thought about that, you're right.

Bill Mann: There's MannKind. Are we talking about MannKind?

David Gardner: MannKind, innovative, inhalable insulin.

Bill Barker: ManTech.

Bill Mann: Yeah.

David Gardner: I'm not sure I had that one on my list. I have ManPower Group, ticker symbol, MAN. Just one N.

Bill Barker: ManTech, which we wrote up in one thing because it has the Ticker symbol MANT. Which the MANT figured into a movie. Do you remember this movie?

Bill Mann: It sounds like a trauma movie.

David Gardner: Mantis?

Bill Barker: It was a movie about watching a movie. It was an atomic creature the Mant which was a combination of a man and an ant.

David Gardner: I missed that one. Matinee. I think it was John Goodman, Matinee.

David Gardner: Nice.

Bill Barker: I was going to say.

David Gardner: I still don't think I'm going to see it.

Bill Barker: The movie within the movie was Mant.

David Gardner: The only interesting thing about the movie was just spoiled. By the way, another MAN, MAN U, Manchester United, public company.

Bill Mann: Manas Man, the Germans.

David Gardner: Do you own any of these, by the way? Do you have any mans in your portfolio?

Bill Mann: It's so funny because a long time ago, I read Jason's Zweig, Your Money, and Your Brain, and he actually made a point that people tend to be attracted to companies that have their names in them. I've had that in the back of my mind like, am I being convinced by virtue of the fact that they've named these companies after me?

David Gardner: What about bill.com? Does either of you own bill.com?

Bill Barker: No.

David Gardner: Maybe Zweig was overstating his point.

Bill Mann: Well, maybe we are at the counterpoint. If he named it william.com, I don't think I'd be able to resist.

David Gardner: Stock number five is one of these companies, but not one we've already named. Manhattan Associates, M-A-N-H, MANH is a public company that helps businesses run their supply chains more efficiently. They create software, offer services that help companies manage their inventory, fulfill orders faster, improve customer experience across different shopping platforms, Manhattan Associates. Again, the ticker symbol, M-A-N-H, Bill Mann. What is your stated market cap range for Manhattan Associates?

Bill Mann: With two Ns. I'm going to say $950 million to $4.1 billion.

David Gardner: Sub $1 billion, $950 million to $4.1 billion. Bill Barker players at home. In fact, Bill, before I turn to you, any thoughts about Manhattan Associates, Man names, or Bill's call?

Bill Barker: I had decided early on to just disagree with his range [laughs] regardless of what it was given given my utter lacking knowledge about the company.

David Gardner: I think that's not a lot of people know this company.

Bill Barker: That's what I'm going to stick with.

David Gardner: You're going to disagree.

Bill Barker: I'm going to disagree.

David Gardner: Players at home, agree or disagree? Bill disagreed. If you disagreed with Bill Barker, give yourself a plus one. It worked again. I'm not going to say you should keep pursuing that strategy all show long, Bill.

Bill Barker: I'm going to say a 12 billion.

David Gardner: Fourteen point three three billion dollars. This is a company, by the way, founded in 1990, because I always like to check when and also where, not Manhattan, it's based in Atlanta, Georgia. But a six-bagger over the last 10 years. A couple of fool wrecks just this year. I don't know if either of you guys are working behind that.

Bill Mann: You would hope that I'm not, [laughs] but no, the answer is no.

Bill Barker: No.

David Gardner: Awesome.

Bill Mann: It would be great if Manhattan Associates was actually from Manhattan, Kansas.

David Gardner: Because Kansas State University is in Manhattan, Kansas.

Bill Mann: Yeah.

David Gardner: We're at halftime. Now, Des, in the past, for this show, we've occasionally played a Halftime Follies, quick music. I'm not going to say you should top what Rick Engdahl has previously bought to this podcast, but if you wanted to have a very short, but extremely special Halftime Follies Music show, now is your moment. Guys, that actually makes sense because Des is a very talented viola player. They don't normally get to march with the bands, though.

Bill Mann: It's a shame that they don't.

Bill Barker: It's more difficult to play some wacky tune like I'm envisioning the Follies music on a viola. It's a more stayed and august instrument, you know, the Wurlitzer.

Bill Mann: Which also not great for marching.

David Gardner: That was the halftime show. Let's move on to the second half of this week's Market Cap Game Show. I showed as Bill Barker, three, Bill Mann, two. Let's turn now to Bill Barker for stock Number 6. Bill, I wouldn't expect in all areas of your life, but what is an area or two where you enjoy staying ahead of the curve, knowing the latest trends and insights before they become mainstream?

Bill Barker: Hygiene. [laughs] Is that it? You would hope.

David Gardner: I asked Bill, not Bill.

Bill Mann: Sorry. I was just trying to help.

Bill Barker: Areas where I like to stay ahead of the curve, boy, that's a tough subject, because I'm pretty far behind.

Bill Mann: Can you see the curve somewhere?

David Gardner: That's part of your charm.

Bill Barker: I like to be more ahead of the curve on what.

Bill Mann: Sarcasm. You're ahead of the curve.

Bill Barker: [laughs]. I would say, racket sports, getting ahead of the curve on the newest ones in new territories.

David Gardner: Have you been a fan of tennis basically taking out the questionable calls of the empires and making it technology-driven?

Bill Barker: Yes. I think that, sooner or later, baseball will be doing that with.

David Gardner: I think so too.

Bill Barker: Why it doesn't yet. There are empires unions and reasons like that. Yes, tennis.

David Gardner: Tennis has paved the way for baseball to make that eventual change.

Bill Barker: In the old days, it was really annoying to have people arguing calls, and there's no solution.

David Gardner: It was entertaining. John McEnroe scored some good TV ratings back in the day cause he would just have this prolonged shout.

Bill Barker: Sometimes, once, he got thrown out because he violated the rules.

David Gardner: Of a tennis match. [laughs].

Bill Barker: Of the Australia Open. He was thrown out.

Bill Mann: Let's set the table here. He deserved it.

Bill Barker: He didn't even argue. He thought the rule had changed, and there was one fewer warning that was implemented in this new year. As soon as he was defaulted, he realized, oh, I thought I had one more outburst permissible, [LAUGHTER] because he could always reel it back in.

David Gardner: Well, let's forget about you for a sec, because you didn't want to go there, but let's pretend you're a company. Do you think having access to cutting-edge insights and trends within your industry could give you a strategic advantage? Would that be worth paying for?

Bill Barker: It's certainly something that I would claim, if I were..

David Gardner: Well, speaking of names that resemble our own names, this public company, ticker symbol IT has a name frighteningly similar to your host and MCs this week, Gartner Inc. Has been around for quite a long time. It's been a good stock pick. In fact, I was checking my brother, Tom, pick this for Stock Advisor on March 15th of 2013. Great pick, Tom. I'm not going to say how much it's up, we'll do that in a sec. But let's go to the market cap, Bill Barker. These are the guys behind the Hype Cycle, which is a good framework I've enjoyed talking to. They are the magic quadrants of the different industries. I think a lot of us, especially if you're in the business IT world, you've heard of Gartner.

Bill Mann: I'm sure they haven't spelled their name right.

David Gardner: The funny thing is that, my great-grandfather, who was Danish, came to this country and changed his name from Gartner to Gardner to anglicize it. We are Gardner today, but this is actually our family name, even though it's not. Wish I owned some shares of this company. But I don't. Ticker symbol IT, Bill Barker, what is your stated market cap range for Gartner?

Bill Barker: I'm going to say, 20-35 billion.

David Gardner: Twenty billion to $35 billion. Bill Mann, players at home. Bill, do you like Gartner? Do you have any opinion about Gartner? Do you father stuff?

Bill Mann: Not really. Actually, I know it'd be way cooler if I did for the sake of the show.

David Gardner: Well, I'll say one thing. The companies that appear pop up in their magic quadrants make a lot of that. I see it often on websites. We're in this, we're a leader in Gartner's quadrant around telecom. You may not be a huge Gartner fan or follower, but you're now under pressure to either agree or disagree with Bill's stated range. He went back around numbers again, by the way, 20 billion to 35 billion players at home. Bill Mann, agree or disagree?

Bill Mann: I'm going to disagree.

David Gardner: Unfortunately, we have our first separation because you should have agreed. Bill did a pretty good job. It was tight. The market cap for Gartner is 34.7 billion right near the high end of Bill's 20-35 range. Therefore, if you agreed, give yourself a plus one. Players at home. Bill Barker has four, Bill Mann has two. I hope you have six. Let's move on to Stock number 7. Oh, my gosh, I was waiting for this to happen. We have a throw down. Players at home, both Bills will now write down their market cap range for Stock number 7. Of course, we're going to talk about it first. Pencils out. Then once Bill Mann and Bill Barker state their market caps, you're going to decide which range seems more plausible to you. Senor Mann's or senor Barker's, and if you guess right, give yourself a point. If both are right, by the way, the tighter range wins the point. If they're both wrong, if the market cap actually fell outside, that would never happen, but if it did happen, whoever's closer to the actual market cap would get a plus one. Again, this is a throw down. We do this twice every show, Stock number 7. Let's briefly talk about dividend yields, though, Bill Mann. Do you purpose dividends in the stocks that you pick personally or for our services?

Bill Mann: For certain companies, I think that there is a certain amount of discipline that comes from having a payout that goes to shareholders. I prefer companies that do stock buybacks and reduce the overall float of the shares, which is another form of return of capital. But dividends, I like getting those checks.

David Gardner: Free money. I did a podcast for this podcast last week about Pet Perks. The things that make everything a little bit happier? The opposite of Pet Peeves. Dividend Day. I mean, oh, I got money in my account. Look, honey, it's Dividend Day.

Bill Mann: They love me.

David Gardner: That's nice. Maybe it's as we get older, we appreciate that a little bit more. Now, high yields can be deceptive. Some stocks may offer unusually high yields due to financial distress. They might be unable to pay it going forward, but people see the yield, and they go, wow. Others though, other companies are designed for higher yields. Bill Mann, what specific level, this is a one-on-one question. We're no longer in Investing 10, we're now up to Investing 101. What is a specific level of dividend yield that would catch your attention in today's market in a good way? Then at what threshold would you start to question, raise your eyebrows skeptically at its sustainability? We're talking about the level of dividend yield where you love it, and then where you wouldn't love it.

Bill Mann: Any company that has a dividend yield above 3% has my attention. I understand that in this day and age, that is actually below the rate of inflation, and it is below the prime rate that you can get in a savings account at this point, but it is still, with most companies, you're not counting on just the dividend. A 3% yield, I would consider to be a well yielding company. Any company that has a yield 8% or higher with the exception of certain types of [OVERLAPPING] a REIT. Exactly.

David Gardner: Real estate investment trust.

Bill Mann: I would assume is distressed.

David Gardner: Well, spoiler alert, and you guys can factor this in during this throw down round. This company's dividend yield is 6.82%, which is actually under the REIT. I thought you might.

Bill Mann: Do I get a point?

David Gardner: You don't, but you do get a four star [OVERLAPPING] and a lollipop later, if you remind me. But Verizon Communications is actually paying out a dividend yield these days of just over 6.8% annually. Gentlemen, this is the throw down stock. I see your pencils out. You are thinking about your tightest most accurate market cap range in which ticker symbol VZ, Verizon Communications falls. Verizon Communications, guys, your numbers are locked in. I do want to mention before we find out your ranges, and then ask our listeners, do you agree with Bill Mann's range or Bill Barker's range? But I do want to point out that the S&P 500 is up 175% over the last 10 years. Pretty good run last 10 years. Verizon over the last 10 years, wait for it. Verizon over the last 10 years is down 23%. This is a very large important American company that has dramatically underperformed over the last decade. Just pointing that out, let me turn to Bill Mann. Bill, what is your market cap range for VZ?

David Gardner: I can tell looking at Bill Barker's face that we may have another unprecedented moment in which neither one of us get the actual number.

David Gardner: That doesn't ever happen on the show. That's never happened.

Bill Mann: I wrote 90 billion to 130 billion.

David Gardner: Ninety billion to 130 billion. Bill Barker, what is your range?

Bill Barker: I have no confidence. Thirty to 65 billion. I mean, the dividend being that high is deeply suspicious.

David Gardner: Again, players at home, do you want to agree with Bill Barker's, 30-65 billion or Bill Mann's, 90-130 billion. You make the call now 3, 2,1, say Barker or Mann. Thank you. I may have influenced you, and in which case, I'm glad I did, because that's what we're doing. We're influencing each other all the time with fun facts like, wow, Verizon is paying 6.8% dividend yield?

Bill Mann: Less fun facts, it's down 23% over a decade?

David Gardner: Also some embarrassing facts that neither of you guys got this one right, which never happens on this show. It's true that you were both low, and I think I may partly be at fault by pointing out what an underperformer Verizon has been. But the market cap for Verizon is $166.10 billion at this week's Monday close, which means it exceeds both of your range more than doubling Bill Barker's. Bill, apparently, you're a Verizon hater.

Bill Barker: No. I think if you had not given that information, I would have been a lot closer. It's not like it's struggling to the degree that I [OVERLAPPING] .

David Gardner: I like my files. I'm a customer.

Bill Barker: I would be like, that's somewhere. I don't know, 100-200 billion. Ever I'm not quite sure who knows.

David Gardner: It's 166.10 billion.

Bill Barker: But the dividend range, that's a big chunk of money.

David Gardner: I agree.

Bill Barker: But they're paying out [OVERLAPPING] the market cap that high.

David Gardner: Part of the reason people listen is to play along with us. I think the other reason people listen is to learn about some new comies or special situations, maybe like this one. I also just love hearing you guys talk about investing. Bill, I appreciate your point about dividend yields, and 3% raises your interest. Eight percent which is still well above Verizon would start causing you to be very skeptical. That's valuable advice. Thank you. Give yourself a plus one, Bill Mann.

Bill Mann: I was waiting for that part.

David Gardner: Barker four, Mann three, again. If you said Bill Mann, give yourself a plus one, Bill was closer, his high end was 130 billion. Let's move on to Stock number 8. On to Stock number 8, now, I often mention that I randomize what stock is coming up. Let me just briefly explain that process just so people understand where these are being pulled from. On the Motley Fools site, for our members, we list stocks by various rankings. The one that I find most interesting is just the top 500 that are of most interest to our members. I call them the Fool 500. There's no S&P 500 gamesmanship going on here. Just 500 is a good round number. It's a lot of different stocks. I just sit there and I randomize two numbers, 1-500. Then I look at those two companies, Number 437 and Number 28, and I decide, which would be more fun to talk about on the Market Cap Game Show? Occasionally, I get one that is so obscure, but it's the number that I came up with, and it's better than the other one that I talk about a company like the one we're about to go to for Stock number 8. Bill Barker, I know you are a man of the world. You know much about the world. Do you know anything about B cells?

Bill Barker: B cells.

David Gardner: B cells.

Bill Barker: As in the thing that stains you?

David Gardner: Human body. Big letter B.

Bill Barker: The letter B.

David Gardner: Not T cells, but B cell.

Bill Barker: I obviously don't.

David Gardner: Nor did I. Therefore, I looked it up. B lymphocytes are a type of white blood cell that plays a crucial role in our immune system. They originate and mature in our bone marrow. There's at least a mnemonic B cells, bone marrow, and are essential for the adaptive immune response. Company number 8 is a smaller, spoiler alert, though real spoiler, there smaller biotech company focus, well, really founded with one goal in mind to leverage scientific advances in B cell biology to develop novel treatments for patients. I saw the ticker symbol TGTX, and I thought, Target Stores with an X. I'm not really sure what this company is. This is not a hugely well-known company, but it is in our Fool 500. TG Therapeutics. Bill Barker, is the company. I'm turning to you for Stock number 8, and asking you, what is your stated market cap range for TG Therapeutics, ticker symbol TGTX?

Bill Barker: One to three billion.

David Gardner: Not beating around the bush there, Bill Mann. Players at home, one billion to $3 billion. Bill Mann, I know you know a lot. You have an encyclopedic knowledge, at least of restaurants and random stores, which we haven't even got to. Did you know what B cells were? You can lie.

Bill Barker: No, I didn't. My biology-inspired daughters would both be incredibly angry with me that I did not know.

David Gardner: Well, you've just learned something. They don't need to listen to this podcast. They probably don't. They'll never know that dad didn't know it, until he did.

Bill Barker: They are telling me right now they are both shouting the exact market gap. I'm sure, because, you're lost on this one as a am.

David Gardner: Bill Barker has said 1 billion to $3 billion. Bill Mann, players at home, agree or disagree?

Bill Barker: It's such a good range. I'm going to disagree.

David Gardner: Unfortunately, you should have agreed because you were right, it was such a good range. That market cap for TG Therapeutics, $2.56 billion. This is a company dedicated. This is from its website, to the simple concept to the study of B cells and B cell diseases. To achieve its goal, they searched the globe looking for medicines and early research that they believe could become viable treatment options for patient's B lymphocytes, $2.56 billion score a point for Bill Barker. I believe that makes it 5-3 right now, Bill Mann.

Bill Mann: Thanks for bringing that up on the edge of elimination.

David Gardner: Bill is pretty good at tying things up and sending us into sudden death. We'll see if he can manage that as we move on a Stock number 9. Bill Mann. you start a company. I know you did this in the past.

Bill Mann: I did.

David Gardner: Actually, let's just say it's in the wireless communication space. You name it, well, keys back to our conversation earlier. You name it Mann Voice Solutions.

David Gardner: There's this other company that provides complimentary solutions, and we'll call it Barco Cortech. You guys decide to merge. Bill Mann, how would you likely choose to name that new merged company? You want to take a shot at maybe naming it yourself? Again, Mann Voice Solutions merging with Barco Cortech, or would you hire a naming firm or consultant to invent you a new brand name?

Bill Mann: It's got to be something like Flavity, maybe there's a couple of Xs involved. Definitely weird capitalization.

David Gardner: Is this part of your background? Were you a brand name firm consultant guy?

Bill Mann: No, but I did have to name a company one time, and it was a disheartening experience.

David Gardner: Was it your own company?

Bill Mann: Yeah.

David Gardner: Did you go with Mann Voice Solutions?

Bill Mann: I did. That's exactly what it was.

David Gardner: That's definitely news to me.

Bill Mann: No, that definitely wasn't it.

David Gardner: I have no strong view for or against the name chosen for this company, but when TriQuint Semiconductor and RF Micro Devices merged in the year 2015, combining their expertise and resources to become a leading provider in radio frequency and semiconductors, they decided there are two keywords. Again, TriQuint Semiconductors, RF Micro Devices.

Bill Mann: Please tell me it was FQuint.

David Gardner: Their two keywords were core and voice, and thus Qorvo was born, Q-O-R-V-O.

Bill Mann: Almost as good as having an X as having a Q with no U.

David Gardner: I'm turning back to you, Bill Mann. Now, this is a space, I don't know if you know anything about this company, I know you know something about this space, but more importantly, do you know the market cap of Qorvo, ticker symbol QRVO, What is your stated market cap range?

Bill Mann: It is somewhere between $17 billion and $24 billion.

David Gardner: $17 billion to $24 billion. Bill Barker, are you presently, or at any time in the past, have you been a principal at Barco Cortech?

Bill Barker: No.

David Gardner: I think I came up with Barco because it sounded like Qorvo, and it just sounds stupid.

Bill Mann: Wasn't that, like a front company for your terrorist asset chasing IS? You had to have front company, didn't you?

David Gardner: Or maybe it was his competitor to Chewy Barco Cortech.

Bill Mann: Internet for dogs.

Bill Barker: I helped my wife name her consulting company, and in the process of just filling out the form, she's like, We have to have a name for this, and so almost no thought was given to it. Just like her name and what it did.

David Gardner: It probably saved a lot of time, and maybe some money, too.

Bill Barker: It was decided on a more expansive name for what the services would be than she actually provides so that she could expand into that area at some point, but I think it doesn't end up helping. It's not specific enough about what she actually does. I'm like all for one, I would say, on naming.

David Gardner: Well, let's see for the market cap of Qorvo. Bill Mann said 17 billion to 24 billion rocking the round numbers. Bill Barker players at home, do you want to agree or disagree?

Bill Barker: He expressed that with a confidence that I think is undeserved. I think that he was trying to play me. The fact that he has not gotten, I believe, a range right yet leads me to believe that disagreeing with it is my best play.

David Gardner: Part of me wants to think that you're wrong about that and you're being a little cocky, and you don't deserve to be right yet again. Yet, the other part of me admires that you just nailed it once again, Bill Barker, because you should have disagreed. Qorvo's market cap $10.92 billion. That means a couple of things. First of all, it means you now have a guaranteed seat in the Market Cap Game Show World Championship of 2025.

Bill Barker: Yes.

David Gardner: You're going to win this week, and that doesn't preclude Bill from maybe making a later appearance, but it does.

Bill Mann: It should.

Bill Barker: Though unlikely. Given how good he seems to be at this game. Seems like he'd have to be given all the chances.

David Gardner: Let me turn back to Bill Mann. Obviously, we're still gonna play the last one because we do this for players at home. It's not about us making it to next year or not.

Bill Mann: It kind of is.

David Gardner: Bill Mann.

Bill Barker: That's the kind of attitude that cost you. If you've been thinking of the listeners the whole time, maybe you'd be in the lead right now. Probably not, but whatever you were doing was the wrong tactic.

David Gardner: This stock has risen 190% over the past decade since that renaming, market's up 175% as I mentioned, so it's a market performer just ahead. But Bill Mann, do you know where this company's based?

Bill Mann: No. I would guess California.

David Gardner: Where did you grow up?

Bill Mann: Raleigh, North Carolina.

David Gardner: Close. Do you ever go over to Greensboro? Spend any time at Greensboro?

Bill Mann: I have been known to.

David Gardner: You could visit the Qorvo headquarters. It is at Greensboro. Now, I think we have to bring this back. Where should I eat right after I visited Qorvo headquarters?

Bill Barker: Within 2 miles of the headquarters.

David Gardner: Geo located. Yeah, that's a lot of pressure on Bill. Do you have a place for us in Greensboro? That's my question.

Bill Mann: Stemie's Barbecue.

David Gardner: Okay, thank you. That sounds great. Qorvo and Stemie's. Stemie's a merger of two other barbecues that had totally different names, no doubt, they came up with Stemie after a long, expensive consultation.

Bill Mann: I'm going to guess Stemie was actually the nickname of a large man who cooked barbecue.

David Gardner: Well said.

Bill Mann: I'm guessing.

Bill Barker: The very slightly built men who specialized in barbecue being rather unique subset of the Barbecue world.

David Gardner: All right, we're going to move on to stock Number 10. This is a throw-down so we're putting that out right ahead. So both Bills have their pencils out, as I turn briefly to Bill Barker and say, Bill, do you mind if I ask you a personal question. I've done that on this show before.

Bill Barker: Well, I don't know yet.

David Gardner: I know. How about this? It's not so personal. Since it shows up on your driver's license, can I ask you a question?

Bill Barker: Yes.

David Gardner: Do you intend to be an organ donor?

Bill Barker: Yes.

David Gardner: Do you think everybody should?

Bill Barker: Yes.

David Gardner: How militant are your views in that regard?

Bill Barker: Everybody who is not an organ donor should be jailed.

David Gardner: That's pretty militant and obviously, we're making a lot of it somewhat, but I think it's a nice thing to. I also have checked that box. So I have a little red heart on my DC driver's license that says, I'm an organ donor, maybe you are too.

Bill Barker: I can't remember. I hope so. My entire life was supplied by organ donation in the sense that, not that I'm the recipient of one, which would be something.

David Gardner: We would talk more about that.

Bill Barker: We'll talk more about that. No. My dad was an organ transplant surgeon so that funded a lot of my education.

David Gardner: That is so interesting. Thank you for sharing that. Company number ten has built its business around an entire system to care for and preserve, assess organs for potential transplantation. TransMedic Group's Organ Care System or OCS, if you will, is behind their fabulous first quarter 2024 revenue growth. They turned in about $100 billion in revenue for the first quarter this year. That's up 133% over that same quarter a year ago. The ticker symbol is TMDX. This is a Fool favorite. There are a lot of Fool recommendations. A lot of Fools listening to us right now who probably have the stock. By the way, let me briefly recall about Verizon this. I invented a fun ratio. Here it is. The number of official Fool recommendations for Motley Fool Services, that's the numerator. In the denominator is the market cap of the company. One of the lowest ratios. Again, number of Fool recs up top, market cap down below would be Verizon. Verizon has received one recommendation in its history, our history of the Motley Fool, and it has $166 billion market cap. That's a tiny number. This company's the opposite. This is a smaller company with a lot of Fool recs. Interesting, the Fool interest ratio, if you will. I think you've written down your market cap, so I see you guys, well, at least one of you has written down your market cap. I was trying to stall for you, Bill Mann. Get the pencil out. Okay, good. Now for Stock Number 10, a reminder. Bill Mann chin up, because people usually only remember what happened at the end, so if you can nail this, this could really change the public's perception of this hour.

Bill Mann: So a bit of a personal story, but the last place my wife lived when she was in college and undergrad in Philadelphia was about three doors down from what is now the Clyde Barker Transplant Center at the University of Pennsylvania. I guess Bill wins that story.

Bill Barker: The entities that have transplant centers named after them, or houses that provide a place for families to stay when their beloved ones are recovering is, I think my dad and Ronald McDonald. The Ronald McDonald houses got there first. I have more of them, hopefully, we'll just buy out Dad's ones.

David Gardner: McDonald's makes a reappearance in this podcast. That's really great. Thank you. Congratulations. What a remarkable family you're from, Bill Barker. Let's hear from you first, Bill Barker. What is your stated market cap range for TransMedics?

Bill Barker: 6.2 to 7.3 billion.

David Gardner: You had 6.2 to 7.3. Bill Mann.

Bill Mann: 1.2 to 2.1 billion.

David Gardner: 1.2 to 2.1 billion. Players at home. You now need to decide, do you want to go with Bill Barker, 6.2-7.3 or Bill Mann, 1.2-2.1? I'm going to give you 3 seconds, and you're going to say, one of their names Barker or Mann 3, 2, 1. You said it. Great. If you said Bill Barker, give yourself a plus one, because TransMedics, guys, you both missed it again, but we'll forget that ever happened on this show. You weren't far off, though. It was in between. TransMedics Group is at 4.71 billion. In between your stated ranges, but a little closer, 1.5 billion away from Bill Barker's. 2.6 away from Bill Mann so, Bill Barker, give yourself a plus one. Players at home, if you agreed with Bill Barker, it seems like that was the way to go this particular week on the show.

Bill Mann: I know I was going with Barker on that one, too. As someone who has recommended it a few times. I figured he might have had a [inaudible].

Bill Barker: No. I've thought about it.

David Gardner: Then there's Barker Center and all the things. Yes. That was probably the right bet to make. Thank you both. So the final accounting is then this Bill Barker seven Bill Mann three. But the two Bills and I know that we're not playing this game for each other, we're playing it for you. How did you score, dear Fool? Dear listeners at home, we hope you outscored all of us. The purpose of the Market cap game show is to make more popular. I'm never going to say as popular as Jeopardy, but to make more popular market caps, the real value of stocks on the market that most people don't understand, except that you do understand because you just listened to us for an hour. I hope you scored at least a few points this week and maybe beat one or both of our competitors, Bill Barker and Bill Mann. You both distinguished yourselves, help make the world a bit smarter, happier, and richer. Next week is our June 2024 mail bag. This month has featured ChatGPT interviewing me with some of its most provocative and challenging questions about rule breaker investing. Then last week, Pet Perks, not Peeves, would love to hear further thoughts from you about these topics, including our Market cap game show this week. Would you like to be on next week's show? Email us rbi@fool.com. You can tweet us at @RBIPodcast. Okay, a last line from you, Bill Mann.

Bill Mann: Well, I'm so glad I was here this week to make the world feel smarter, specifically, smarter than me. The good news for me is that there's no reason at all for me to consult the Oracles or the grand Counsels. That was a thorough victory by William Barker, and for which all of the plaudits that are coming his way are earned.

David Gardner: So gracious. Bill Barker, do you feel an instinct to be as gracious to your competitor as he just was to you?

Bill Barker: Of course, parsing some of that and trying to think of how many plaudits there were.

David Gardner: What exactly did he just say?

Bill Barker: I think it rounds to zero.

Bill Mann: There's 0.7 plaudits.

Bill Barker: I don't know how many people will contact me as a result of this, wow, that was really impressive.

Bill Mann: It's already on his LinkedIn.

Bill Barker: I don't have too many other thoughts, except to thank Bill for bringing up the Clyde Barker Transplant House, and if for any reason, any of the luster of my father's achievements is being reflected on me, that's wrong. Let me just disabuse all listeners any association that I should have with his achievements.

David Gardner: All right. Well, that's a wrap on the June 2024 Market Cap Game Show. I think this is like our 28, 29th or 30th consecutive quarter in a row, a delight it was. Thank you again, to Bill Barker and Bill Mann and you. See you next week for our Mailbag. Fool on.

Desiree Jones: As always, people on this program may have interest in the stocks they talk about. The Motley Fool may have formal recommendations for or against. So don't buy or sell stocks based solely on what you hear. Learn more about Rule Breaker investing at rbi.fool.com.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Bill Barker has positions in Apple and McDonald's. Bill Mann has no position in any of the stocks mentioned. David Gardner has positions in Amazon, Apple, and Cava Group. Desiree Jones has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Apple, Chewy, Manhattan Associates, Qualcomm, Target, and Zoom Video Communications. The Motley Fool recommends Cava Group, Gartner, Qorvo, Sleep Number, TG Therapeutics, and Verizon Communications. The Motley Fool has a disclosure policy.